Doctor profile · Federal record

Dr. Michael Weingarten, M.D.

Rheumatology Physician (CMS: Rheumatology) · West Seneca, NY

  • NPI 1750590253
  • Accepts Medicare
  • MIPS 92.0 / 100 · 2023
  • 22 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3615 Seneca St
West Seneca, NY 142243444
(716) 675-7376
fax (716) 675-2191
Mailing address
5 Mourning Dove CT
Orchard Park, NY 141273000

Credentials & registration

NPPES · NUCC
NPI registered
May 2007 — 19 yrs on file
Profile last updated
January 15, 2013
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
New York #256155

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750590253. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
10,074
Distinct HCPCS
10
Medicare allowed
$373,468
HCPCS Description Services Patients Avg allowed
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,017 22 $33
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 3,025 14 $42
J0897 Injection, denosumab, 1 mg 1,800 20 $23
J7050 Infusion, normal saline solution, 250 cc 288 63 $1
96413 Administration of chemotherapy into vein, 1 hour or less 218 63 $126
96415 Administration of chemotherapy into vein, each additional hour 197 32 $27
99214 Established patient office or other outpatient visit, 30-39 minutes 191 87 $124
J3489 Injection, zoledronic acid, 1 mg 130 26 $8
96372 Injection of drug or substance under skin or into muscle 66 24 $14
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 37 18 $60

In context: peer comparison

Among 1 peers in West Seneca Rheumatology Physician, average services per provider: 719. This provider delivers 14× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$936
Transactions
46
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Pfizer INC. 13 $159.05
Janssen Biotech, INC. 12 $142.19
Abbvie INC. 4 $107.14
Amgen INC. 4 $99.89
Ucb, INC. 2 $56.81
AstraZeneca Pharmaceuticals Lp 2 $45.56
Sandoz INC. 1 $35.61
Actelion Pharmaceuticals US, INC. 1 $34.84
Boehringer Ingelheim Pharmaceuticals, INC. 1 $33.77
GlaxoSmithKline, LLC. 1 $32.79
Kyowa Kirin, INC. 1 $29.82
Aurinia Pharma U.S., INC. 1 $28.51
Novartis Pharmaceuticals Corporation 1 $25.18
Lilly USA, LLC 1 $23.71
Alexion Pharmaceuticals, INC. 1 $22.76

By nature of payment

Food and Beverage
$936

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,815
Patients
337
Total drug cost
$555,800
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 400 71 $13,313
Prednisone Generic 320 76 $4,480
Hydroxychloroquine Sulfate Generic 205 39 $12,891
Duloxetine Hcl Generic 132 23 $2,113
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 126 22 $3,188
Allopurinol Generic 120 28 $2,058
Colchicine Generic 76 18 $2,595
Pregabalin Generic 75 0 $2,076
Meloxicam Generic 72 25 $472
Enbrel Sureclick (Etanercept) Brand 61 0 $504,020

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Weingarten's medical specialty?
Dr. Michael Weingarten practices Rheumatology Physician in West Seneca, NY.
Where does Dr. Michael Weingarten practice?
Dr. Michael Weingarten practices at 3615 Seneca St, West Seneca, NY 142243444. Office phone: 7166757376.
What is Dr. Michael Weingarten's NPI?
Dr. Michael Weingarten's National Provider Identifier (NPI) is 1750590253, issued by NPPES.
Does Dr. Michael Weingarten accept Medicare assignment?
Yes. Dr. Michael Weingarten accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Weingarten commonly perform?
Top Medicare-reported procedures in 2023: Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.